Gainers
- Bright Minds Biosciences Inc. (NASDAQ:DRUG) shares jumped 72.8% to close at $2.16 on Monday as the stock continued to see momentum despite the company last week announcing it is not aware of any developments that would explain the recent surge.
- AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC) surged 66% to close at $0.3561 after declining 8% on Friday. Anpac Bio-Medical Science recently named Yuyang Cui as Co-Chairman and co-CEO.
- Summit Therapeutics Inc. (NASDAQ:SMMT) jumped 48.2% to close at $1.63. The company's Co-CEO's recently purchased over 100 million shares of stock in the company.
- Minerva Neurosciences, Inc. (NASDAQ:NERV) gained 47.8% to settle at $4.59 after the company announced it submitted a New Drug Application to the FDA for roluperidone for the treatment of patients with schizophrenia.
- Wag! Group Co. (NASDAQ:PET) jumped 47% to close at $7.63 after jumping around 9% on Friday. DA Davidson maintained buy on Wag Group and lowered price target to $11.
- Bon Natural Life Limited (NASDAQ:BON) gained 36.5% to settle at $2.77.
- Signify Health, Inc. (NYSE:SGFY) shares jumped 32.1% to close at $28.00 following media reports that Amazon.com Inc (NASDAQ:AMZN) may be interested in acquiring the company.
- Blue Apron Holdings, Inc. (NYSE:APRN) gained 26.3% to settle at $6.14.
- Graphex Group Limited (NYSE:GRFX) gained 25.2% to close at $3.13 after gaining 21% on Friday. Graphex Technologies, a wholly owned U.S. subsidiary of Graphex Group Limited, highlighted U.S. expansion progress and outlined business strategy.
- Belite Bio, Inc (NASDAQ:BLTE) jumped 22% to close at $26.84. Belite Bio initiated enrollment for the U.S. Phase 3 clinical trial of its lead asset LBS-008 in patients with Stargardt Disease (STGD1), a progressively blinding disease with no approved treatment.
- ZIVO Bioscience, Inc. (NASDAQ:ZIVO) gained 17.3% to settle at $4.44.
- China Automotive Systems, Inc. (NASDAQ:CAAS) rose 16.8% to close at $4.03. China Automotive Systems recently reported second-quarter FY22 sales growth of 5.5% year-on-year to $127.16 million, beating the consensus of $104.39 million.
- Neptune Wellness Solutions Inc. (NASDAQ:NEPT) gained 16.3% to close at $2.00. Neptune Wellness tweeted ‘Sprout secured several distribution gains with leading retailers, including Target, Walmart, and major supermarket chains. And the largest national pharmacy chain in the United States in 5,000 of their 9,900 doors.’
- Reunion Neuroscience Inc. (NASDAQ:REUN) jumped 15.7% to settle at $4.20.
- Greenbrook TMS Inc. (NASDAQ:GBNH) gained 15.6% to close at $3.55 after jumping around 30% on Friday.
- Cano Health, Inc. (NYSE:CANO) jumped 15.2% to close at $5.55 as traders are circulating Dealreporter chatter.
- Privia Health Group, Inc. (NASDAQ:PRVA) rose 15.1% to close at $41.98. Privia Health recently said Q2 EPS results were higher year over year.
- Saga Communications, Inc. (NASDAQ:SGA) gained 14.2% to close at $28.11.
- Houston American Energy Corp. (NASDAQ:HUSA) rose 13.7% to settle at $4.39.
- Mill City Ventures III, Ltd. (NASDAQ:MCVT) gained 13.6% to close at $3.67.
- NightHawk Biosciences, Inc. (NASDAQ:NHWK) climbed 11.9% to close at $2.54 after the company said it would fund development of a monkeypox vaccine.
- Kiromic BioPharma, Inc. (NASDAQ:KRBP) shares gained 11.4% to close at $0.4200. Kiromic Biopharma said the company has determined not to pursue, at this time, the contemplated public offering to which the registration statement relates.
- Avaya Holdings Corp. (NYSE:AVYA) rose 10.6% to close at $0.8011.
- Better Therapeutics, Inc. (NASDAQ:BTTX) shares gained 10% to close at $1.76. Better Therapeutics recently reported Q2 R&D expenses of $4.2 million.
- AMTD Digital Inc. (NYSE:HKD) rose 8.8% to close at $185.00.
- FedNat Holding Company (NASDAQ:FNHC) rose 8.2% to close at $0.43. FedNat received Nasdaq notification of non-compliance with listing rule 5250(c)(1).
- Vipshop Holdings Limited (NYSE:VIPS) rose 7.9% to close at $10.78 after Credit Suisse upgraded the stock from Neutral to Outperform and announced a $12 price target. Vipshop, on Friday, reported a second-quarter FY22 revenue decline of 17.1% year-on-year to $3.66 billion, beating the consensus of $3.39 billion.
- SaverOne 2014 Ltd (NASDAQ:SVRE) rose 6.5% to close at $2.96.
Losers
- Akili Inc. (NASDAQ:AKLI) shares dipped 49.2% to close at $7.15.
- AMC Entertainment Holdings, Inc. (NYSE:AMC) dipped 42% to close at $10.46 as the company's APE preferred shares begin trading on the New York Stock Exchange. The preferred shares were issued to all common stockholders. The stock may also be down after cinema chain Cineworld said it may file for Chapter 11 bankruptcy.
- Advanced Emissions Solutions, Inc. (NASDAQ:ADES) shares fell 39.8% to close at $3.86 after the company reported a merger with Arq Limited.
- Pharvaris N.V. (NASDAQ:PHVS) fell 34.1% to close at $12.15. The FDA placed a clinical hold on the company's trial of PHA121 for the treatment of hereditary angioedema attacks.
- Genius Group Limited (NYSE:GNS) fell 33.3% to close at $5.17.
- Golden Sun Education Group Limited (NASDAQ:GSUN) fell 30.2% to settle at $35.50 after dropping 23% on Friday.
- iMedia Brands, Inc. (NASDAQ:IMBI) fell 28.9% to close at $1.23 after the company cut Q2 sales outlook.
- Assure Holdings Corp. (NASDAQ:IONM) fell 25.7% to settle at $1.04 after the company reported a proposed underwritten public offering of common stock.
- Cyxtera Technologies, Inc. (NASDAQ:CYXT) dipped 21.3% to settle at $7.25. Cyxtera Technologies recently posted a Q2 loss of $0.27 per share.
- The Singing Machine Company, Inc. (NASDAQ:MICS) fell 20.1% to close at $7.67. Singing Machine Company reported first-quarter FY23 sales growth of 92% year-on-year to $11.6 million versus $6.1 million last year.
- Amarin Corporation plc (NASDAQ:AMRN) fell 19% to close at $1.28.
- Virax Biolabs Group Limited (NASDAQ:VRAX) dipped 18.8% to close at $4.50.
- Volcon, Inc. (NASDAQ:VLCN) fell 18.6% to close at $1.97 after the company priced a $27.2 million convertible senior notes offering.
- GreenBox POS (NASDAQ:GBOX) dipped 17.9% to close at $1.19 amid profit taking after the stock surged last week.
- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) dipped 17.2% to close at $0.7539 Aeglea BioTherapeutics shares jumped 80% on Friday after the company announced a marketing authorization application for pegzilarginase for the treatment of Arginase 1 deficiency has been submitted to and successfully validated by the European Medicines Agency.
- Owlet, Inc. (NYSE:OWLT) fell 16.2% to close at $1.76.
- Bed Bath & Beyond Inc. (NASDAQ:BBBY) dipped 16.2% to close at $9.24. An amended 13D filing recently showed Ryan Cohen has a 0% stake in the company.
- Gracell Biotechnologies Inc. (NASDAQ:GRCL) fell 15.4% to close at $2.86. Gracell Biotechnologies recently posted a Q2 loss of $0.06 per share.
- Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS) fell 15.3% to close at $1.50. Aridis Pharmaceuticals recently posted a Q2 loss of $0.45 per share.
- Hydrofarm Holdings Group, Inc. (NASDAQ:HYFM) fell 15.1% to close at $3.61. The company's co-CEO, last week, disclosed a purchase of 25,000 shares at an average price of $3.73 per share.
- Lizhi Inc. (NASDAQ:LIZI) fell 15.3% to close at $1.16 following last week's Q2 results. The company reported a year-over-year drop in average total MAUs and average total monthly paying users.
- Carvana Co. (NYSE:CVNA) fell 15% to close at $35.96.
- Evelo Biosciences, Inc. (NASDAQ:EVLO) dropped 14.7% to close at $2.21. Evelo Biosciences recently posted a Q2 loss of $0.40 per share.
- ToughBuilt Industries, Inc. (NASDAQ:TBLT) fell 14.6% to settle at $4.14.
- Mobile Global Esports Inc. (NASDAQ:MGAM) dipped 14.5% to close at $2.94.
- Magic Empire Global Limited (NASDAQ:MEGL) fell 14.5% to close at $11.11. Shares of several banks and financial services companies traded lower amid overall market weakness as market participants prepare for the Federal Reserve's Jackson Hole symposium on Friday.
- SkyWater Technology, Inc. (NASDAQ:SKYT) dropped 14% to close at $15.00.
- GigaCloud Technology Inc. (NASDAQ:GCT) fell 13.8% to close at $41.41 after jumping 206% on Friday.
- Canopy Growth Corporation (NASDAQ:CGC) fell 13.6% to close at $3.30.
- Burning Rock Biotech Limited (NASDAQ:BNR) fell 13.4% to close at $3.05.
- Stitch Fix, Inc. (NASDAQ:SFIX) fell 13.3% to close at $5.78.
- Nova LifeStyle, Inc. (NASDAQ:NVFY) fell 13.2% to close at $0.7772. Nova Lifestyle recently posted Q2 sales of $3.80 million.
- Qilian International Holding Group Limited (NASDAQ:QLI) dropped 12.8% to close at $1.16.
- SoundHound AI, Inc. (NASDAQ:SOUN) fell 11.6% to close at $2.8550.
- Femasys Inc. (NASDAQ:FEMY) fell 10.6% to close at $1.82. Femasys recently posted a Q2 loss of $0.22 per share.
- 180 Life Sciences Corp. (NASDAQ:ATNF) fell 10.3% to settle at $0.85. 180 Life Sciences and University Of Oxford announced the enrollment of first patient in a trial of anti-TNF for people with early-stage frozen shoulder.
- Tritium DCFC Limited (NASDAQ:DCFC) fell 9.3% to close at $6.42.
- Asana, Inc. (NYSE:ASAN) dropped 8.7% to close at $20.06. Shares of software and IT companies traded lower as growth stocks sell off on Fed rate hike fears, which has driven a risk-off sentiment.
- Nikola Corporation (NASDAQ:NKLA) fell 8.5% to settle at $5.49.
- UserTesting, Inc. (NYSE:USER) slipped 7.7% to settle at $4.41.
- Heart Test Laboratories, Inc. (NASDAQ:HSCS) fell 7.5% to close at $1.85 after dropping over 10% on Friday. Heart Test Laboratories was recently granted European Patent titled 'Electrode And Cable Connections In Electrocardiography Systems.'
- LendingTree, Inc. (NASDAQ:TREE) dipped 7.3% to close at $35.09.
- GameStop Corp. (NYSE:GME) fell 5.5% to close at $34.50 after dropping around 4% on Friday.
- Amazon.com, Inc. (NASDAQ:AMZN) fell 3.6% to settle at $133.22. Amazon.com has bid for healthcare company Signify Health in an auction that could value it at $8 billion.
- Microsoft Corporation (NASDAQ:MSFT) fell 2.9% to close at $277.75 amid overall market weakness as concerns over hawkish Fed policy pressure stocks.
- Apple Inc. (NASDAQ:AAPL) dipped 2.3% to settle at $167.57. Apple is planning to manufacture the iPhone 14 in India two months after the product's initial release, Bloomberg reported.
